Skip to main content

Table 1 Characteristics of the study population

From: Effects of L-carnitine supplementation on nutritional, immunological, and cardiac parameters in hemodialysis patients: a pilot study

No. 21
Duration of hemodialysis (months) 60 ± 84
Age (years) 73.5 ± 11.6
Gender (male/female) 12/9
Dry weight (kg) 48.0 ± 12.5
Body height (cm) 158.0 ± 10.5
BMI (kg/m2) 19.0 ± 3.2
Comorbidity  
 Cardiovascular disease (%) 23.8
 Cerebral vascular disease (%) 19.0
 HCV Ab-positivity (%) 19.0
Laboratory parameters  
 Blood urea nitrogen (mg/dL) 47.5 ± 15.5
 Creatinine (mg/dL) 6.9 ± 2.8
 β2-MG (mg/L) 25.0 ± 8.1
 Intact PTH (pg/mL) 90 ± 88
  1. Data, means ± SD
  2. BMI body mass index, HCV Ab anti-hepatitis C antibody, β 2 -MG β2-microglobulin, PTH parathyroid hormone, SD standard deviation